This article was downloaded by: [Ryerson University]
On: 09 October 2014, At: 22:54
Publisher: Routledge
Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House,
37-41 Mortimer Street, London W1T 3JH, UK
Journal of the American College of Nutrition
Publication details, including instructions for authors and subscription information:
http://www.tandfonline.com/loi/uacn20
Weight Loss by Telemonitoring of Nutrition and Physical
Activity in Patients with Metabolic Syndrome for 1 Year
Claus Luley MDa, Alexandra Blaik PhDa, Alexander Götzb, Florian Kicherer MBAd, Siegfried
Kropf PhDa, Berend Isermann MDa, Gabriele Stumm MDc & Sabine Westphal MDa
a Otto-von-Guericke University, Magdeburg, GERMANY
b “Die Schwenninger Krankenkasse” Health Insurance, Villingen-Schwenningen, GERMANY
c 4sigma GmbH, Oberhaching, GERMANY
d Fraunhofer Institute for Industrial Engineering IAO, Stuttgart, GERMANY
Published online: 08 Aug 2014.
To cite this article: Claus Luley MD, Alexandra Blaik PhD, Alexander Götz, Florian Kicherer MBA, Siegfried Kropf PhD,
Berend Isermann MD, Gabriele Stumm MD & Sabine Westphal MD (2014): Weight Loss by Telemonitoring of Nutrition
and Physical Activity in Patients with Metabolic Syndrome for 1 Year, Journal of the American College of Nutrition, DOI:
10.1080/07315724.2013.875437
To link to this article: http://dx.doi.org/10.1080/07315724.2013.875437
PLEASE SCROLL DOWN FOR ARTICLE
Taylor & Francis makes every effort to ensure the accuracy of all the information (the “Content”) contained
in the publications on our platform. However, Taylor & Francis, our agents, and our licensors make no
representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the
Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and
are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and
should be independently verified with primary sources of information. Taylor and Francis shall not be liable for
any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever
or howsoever caused arising directly or indirectly in connection with, in relation to or arising out of the use of
the Content.
This article may be used for research, teaching, and private study purposes. Any substantial or systematic
reproduction, redistribution, reselling, loan, sub-licensing, systematic supply, or distribution in any
form to anyone is expressly forbidden. Terms & Conditions of access and use can be found at http://
www.tandfonline.com/page/terms-and-conditions
OriginalResearch
Weight Loss by Telemonitoring of Nutrition and Physical
Activity in Patients with Metabolic Syndrome for 1 Year
ClausLuley,MD,AlexandraBlaik,PhD,AlexanderGo¨tz,FlorianKicherer,MBA,SiegfriedKropf,PhD,BerendIsermann,
MD,GabrieleStumm,MD,SabineWestphal,MD
Otto-von-GuerickeUniversity,Magdeburg,GERMANY(C.L.,A.B.,S.K.,B.I.,S.W.),“DieSchwenningerKrankenkasse”Health
Insurance,Villingen-Schwenningen,GERMANY(A.G.),and4sigmaGmbH,Oberhaching,GERMANY(G.S.),FraunhoferInstitute
forIndustrialEngineeringIAO,Stuttgart,GERMANY(F.K.)
Keywords: metabolicsyndrome,weightloss,telemonitoring
Objective: Mobile technology can improve lifestyle programs, but the monitoring techniques and carer
feedbackneedtobeoptimized.Tothisend,weinvestigatedtheefficacyoftelemonitoringphysicalactivityand
nutritionover12monthsinpatientswithmetabolicsyndromeinarandomized,parallel-group,opentrial.
Methods:ScreeningalloverGermanyyielded184patientswithmetabolicsyndrome.Allpatientsattended
asingle2-hourinstructionmeetingintheirregionconcerningacombinationdietandtheimportanceofphysical
activity.Thereaftertheywererandomizedintoacontrolgroup(controls,n=62)oroneof2differentintervention
groups.Bothinterventiongroupswereissuedaccelerometers,whichmeasuredphysicalactivity,recordeddaily
weightandcalorieintake,andtransmittedthesedatatoacentralserverforusebypatientcarers.IntheActiveBody
ControlProgramofUniversityofMagdeburg(ABC)interventiongroup(n=60),informationandmotivation
wasensuredbyweeklyletters.Inthe4sigmatelephonecoaching(4S)interventiongroup(n=58),thiswas
accomplishedbymonthlytelephonecallsfromthecarers.Clinicalandbiochemicaldataforallpatientswere
collectedat0,4,8,and12monthswithoutanyregularface-to-facemeetingsbetweenpatientsandcarers.The
primaryendpointwasweightlossandthesecondaryendpointwasthepresenceofmetabolicsyndrome.
Results:After12monthsthedropoutratesinthecontrol,4S,andABCgroupswererespectively35%,17%,
and18%.Theadjustedrelativeweightlossesafter12monthswererespectively3.7%,8.6%,and11.4%(all
p<0.000versusbaseline).ABCwasmoreeffectivethan4S(p=0.041);43%ofthepatientscompletingthe
studyintheABCgrouplostmorethan15%oftheirbaselineweight.Thediagnosisofmetabolicsyndromewas
nolongerapplicablein58%ofthecasesintheABCgroup,in41%ofthe4Sgroup,andin33%ofthecontrols.
Conclusions:Telemonitoringofphysicalactivityandnutritionmarkedlyimprovesweightlossandmarkers
ofmetabolicsyndrome.
INTRODUCTION Thecentralcauseofmetabolicsyndromeisobesity,which
hasevolvedintoaworldwideepidemic[2].Thesteadyincrease
A diagnosis of metabolic syndrome is made when abdom- initsprevalenceindicatesthatthemeasuresusedatpresentare
inal overweight occurs together with at least 2 additional risk unabletocurbthisdevelopmentandthatnewandmoreeffective
factorssuchaselevatedtriglycerides,bloodglucose,bloodpres- alternativesareurgentlyneeded.
sure,andlowhigh-densitylipoproteincholesterol[1].Although Obesityhas2basiccauses:anexcessivecalorieintakeand
theexactcriteriaforthepresenceorabsenceoftheseriskfac- insufficient calorie expenditure by physical activity. Though
torsarestillthesubjectofdiscussion,thereisbroadagreement there are numerous programs aimed at modification and con-
that metabolic syndrome carries an increased risk of develop- trol of calorie intake, the number of measures for increasing
ing obesity-associated disorders, in particular type 2 diabetes calorieconsumptionbyincreasingphysicalactivityislimited.
mellitusandcardiovasculardiseases. One major reason for this is that activity programs require a
Addresscorrespondenceto:GabrieleStumm,MD,4sigmaGmbH,Bajuwarenring19,82041Oberhaching,GERMANY.E-mail:gabriele.stumm@4sigma.de
DisclosureStatement:ThisstudyisasubprojectoftheLifescience.bizproject,whichwaspartiallyfundedbytheFederalMinistryforEducationandResearch(BMBF)
andinvolved4sigma,theSchwenningerHealthInsuranceCompany,andtheUniversityHospitalinMagdeburg.4sigmaisanindependentcompanyofferinghealthservices
suchasdiseasemanagement,preventionprograms,andmedicalhotlines.Dr.Stummfrom4sigmawasresponsibleformedicaladvice,generalprojectmanagement,and
coordinationbetweenthestudypartnersanddoesnothaveaconflictofinterests.Allotherauthorshavenothingtodisclose.
JournaloftheAmericanCollegeofNutrition,Vol.0,No.0,1–12(2014)(cid:2)C AmericanCollegeofNutrition
PublishedbyTaylor&FrancisGroup,LLC
1
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
WeightLossinPatientswithMetabolicSyndrome
considerabletimeinputfrombothpatientsandcoaches.There-
fore,approachesthatusemobiletechnologyandtheInternetfor
lifestyle improvements are being developed and tested. Three
recentreviews[3–5]agreethatintheshort-termweightlosscan
beimprovedbytheseprograms.Theyalsoagree,however,that
thepublisheddatadiffermarkedlywithrespecttotechnologies
used,patientgroupsstudied,andstudydurationsandthatfur-
therresearchisneededinordertooptimizetelemonitoringasan
effectivetoolforthemanagementofobesity.
TheActiveBodyControl(ABC)programisalifestylepro-
gram that combines such telemonitoring with a combination
diet, the Magdeburg Dual Diet. This program was first shown
tobeeffectiveinobeseadults[6]andsubsequentlyinpatients
withtype2diabetesmellitus[7].Inthepresentworkweinves-
tigatedtheeffectsoftelemonitoringoveraperiodof12months
in patients with metabolic syndrome in an open, randomized
trialwithparallelgroups.Wealsocompared2differentwaysof
communicatingwiththepatients:byweeklyletters,asroutinely
doneintheABCprogram,andbymonthlytelephonecallsfrom
aspecializedenterprise,4sigma(4S),asanalternativecommu-
nicationpathway.
Fig.1.Flowchartfromscreeningtotheendofthestudy.
MATERIALSANDMETHODS
PatientsandInterventions
use of antidepressants, neuroleptic or cortisol therapy, thyroid
Thepatientswererecruitedbyadvertisinginseveralmajor dysfunction, active cancer or other severe and life-threatening
companiesinsouthernandwesternGermanyandbyanewspaper diseases, disabling disorders of the motor system, pregnancy,
advertisementintheregionofMagdeburginnortheastGermany. orchangesinoralcontraception.Onehundredeighty-fourper-
Interested persons visited either their company doctors or the sonsmetthesecriteriaandwereinvitedtoa2-hourinstruction
lipid clinic of Magdeburg University Hospital. None of these meeting. These meetings were held only once in each of the
patients hadparticipated inanearlierstudycarriedoutbythe participating8regions.Theinstructionconsistedof2parts.All
authors.Fivehundredsixty-fourindividualswerescreenedand individualsparticipatedinthefirstpart,whichincludedanex-
receivedcondensedinformationaboutthetrial,andfastingblood planation of the Magdeburg Dual Diet and the importance of
samples were then collected to test for inclusion or exclusion physical activity (details of both are given below). After this
criteria concerning the metabolic syndrome (see the flowchart basicinstructionthesubjectswererandomizedbylottooneof
inFig.1). 3 groups: controls (n = 62), ABC (n = 60), or 4S (n = 62).
The criteria for diagnosis of metabolic syndrome accord- Thedifferentfinalgroupsizesafterthe8meetingsareaconse-
ing to the International Diabetes Federation recommendations quenceofthefactthatthecohortsineachofthe8participating
[8] were as follows: waist circumference > 80 cm in females regions were not necessarily a multiple of 3. The patients in
and > 94 cm in males plus any 2 of the following 4 factors: thecontrolgroupthenleft,andtheremainingsubjectsreceived
triglycerides≥150mg/dl(1.7mmol/L),high-densitylipopro- theiraccelerometersandinstructionsontheiroperationanddata
tein cholesterol < 50 mg/dl (1.29 mmol/L) in females and transmission.Becausetheinterventioninvestigatedinthistrial
< 40 mg/dl (1.03 mmol/L) in males, systolic blood pressure waspurelytelemedical,therewerenoadditionalappointments
(BP) ≥ 130 or diastolic BP ≥ 85 mmHg or treatment of any with the patients except for determination of their biochemi-
oftheaboveconditions,andfastingbloodglucose≥100mg/dl calandclinicalparametersafter4,8,and12months.Itshould
(5.6mmol/L).AtelephoneandaccesstotheInternetviaaper- beemphasizedthatall3groupsreceivedidenticalinstructions
sonalcomputerwererequired.Theexclusioncriteriawereage abouttheMagdeburgDualDietandidenticalrecommendations
lessthan30orover60yearsanddiagnosisofdiabetesmellitus, concerningphysicalactivity.Thedifferencebetweenthe2in-
coronaryheartdisease,chronicheartfailure,orcerebrovascular tervention groups and the control group was merely the tele-
disorders, as well as other conditions possibly co-influencing monitoring of physical activity and nutrition by means of the
physicalactivityorbodyweight,suchaspsychiatricdisorders, Aipermotioninstrumentsandtheregularfeedbackfromcarers,
2 VOL.0,NO.0
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
WeightLossinPatientswithMetabolicSyndrome
eitherbyweeklyletters(ABCgroup)orbymonthlytelephone UsingtheABCplatformonthisserver,theABCcarergener-
calls(4Sgroup). atedweeklyindividualreportletters,whichweresentouttoall
The Magdeburg Dual Diet is a combination of 2 diets. ABCpatientsbymail.Eachlettershowedthepatient’sweight
The first consists of conventional calorie restriction, lowering loss curve from the beginning of the intervention (a red line)
the calorie intake by 500 kcal per day. The second is a low- togetherwithweightlosscurvesoftheotherparticipantsinthis
carbohydratediet,developedoriginallybyLudwig[9]andmod- group(blacklines).Asecondgraphshowed,foreachdayofthe
ifiedbyWorm[10].Emphasiswasplacedonpreferenceforcar- precedingweek,thedurationofsensoruseasapercentageof
bohydrateswithlowglycemicindex(GI)butnotonavoidance 24hours,thekilocaloriesusedupbyexercisewith4coloured
ofcarbohydratesasintheAtkinsdiet[11].Manypracticalex- barsreflectingthe4activityintensitiesfrom“passive”to“jog-
ampleswerepresented,andabookletwasdistributedcontaining ging,” and the distance covered in kilometers. A third graph
anoverviewoftheaimsandbackgroundofthestudy,atableof showed the cumulative number of kilocalories from nutrition.
caloriecontents,andatableofGIvaluesforabroadrangeof Finally,theletteralsocontainedcommentsassessingprogress
carbohydrates. overthepastweekaimingtomotivatethepatients.
Asfarasexercisewasconcerned,thesubjectswereadvised Patients inthe4Sgroupreceivedamonthlytelephone call
toincreasetheirusualdailyphysicalactivity,likewalkingorcy- from specialist doctors and nurses from the 4sigma company
cling,ratherthantoengageinparticularsports.Therecommen- in Munich, Germany. This company specializes in telephone-
dationwastoperformtheseactivitiesmoderatelybutsteadily, basedhealthcoachingincludingtheuseoftelemonitoring.The
slowlyenoughtobeabletotalkatthesametime[12],andto callstookonaverage20minuteseach,andthecarersusedthe
keepthepulsebelow120/min. same ABC platform described above but communicated and
TheaccelerometerusedwasanAipermotion440modelfrom commentedonthedataverbally.
AipermonGmbH(Munich,Germany).Theaccelerometerswere The study was approved by the Ethics Committee of the
programmed individually for each patient, with an allowance SchoolofMedicineandallsubjectsprovidedwritteninformed
forage,sex,weight,andindividualsteplengthsfor3walking consent.
speeds:normal,fast,andjogging.Theinstrumentscalculatethe
currentanddailydistancesatthe3walkingspeedsandthecur-
BloodSamplingandLaboratoryMeasurements
rentanddailyexercise-relatedenergyexpenditureinkilocalories
and displaystheresultsonascreen.Movements that areonly Blood samples were taken from the antecubital vein after
inadequatelyrecordedbytheinstrument,suchasswimmingor a12-hourovernightfastandsentbymailtothecentrallabora-
cycling,aremanuallykeyedinaccordingtotheirdurationand toryatMagdeburgUniversityHospital.Alllaboratorytestswere
intensity. The validity of these measurements has been satis- donebycommercialenzymaticmethodsinarandom-accessan-
factorily demonstrated by comparison with spiroergometry in alyzer(Modular,RocheDiagnostics,Mannheim,Germany)in
differentpatientgroupswithheartfailure[13]andbycompari- serumforallparametersexceptglucose,whichwasdetermined
sonwiththe6-minute-walktest[14].Thepatientswererequired in sodium fluoride plasma. Hb was determined in EDTA
A1c
to carry the matchbox-sized instrument in a little holster tied tubes by high-performance liquid chromatography (Variant II,
tothebeltfromthetimetheydressedinthemorninguntilthey Bio-Rad,Munich,Germany).Thehomeostasismodelofassess-
undressedintheevening.Theinstrumentmeasuredthedailydu- ment(HOMA)indexwascalculatedaccordingtoHaffneretal.
rationofactiveusageandtransmittedittothecarer,expressed [15].Bodyweight,height,waistcircumference,andbloodpres-
aspercentageof24hours.Anadditionalfeatureoftheinstru- sureweremeasuredbytheinvestigatingdoctorsatbaselineand
ment is the recording of meal calories in a simplified form. then at 4, 8, and 12 months. Blood pressure was determined
Theregistrationofnutritionalcaloriesoccursfirstbyselection usingmanualsphygmomanometers.
ofthemeal;forexample,“breakfast,”“snack,”“mainmeal,”or
“drink”followedbychoiceof“mini,”“normal,”or“maxi.”How
StatisticalAnalysis
todeterminemini,normal,ormaxiwascoveredinthe2-hour
training.Althoughtheactualcalorieintakecanonlyberoughly Theprimaryaimoftheanalyseswastocomparetheresults
assessedbythisapproach,thereisasatisfactorypsychological betweenthedifferenttreatmentarms.Theprimaryendpointwas
effectbecausethepatientsarecontinuouslyawareoftheirnutri- theweightlossfrombaselinetomonth12asapercentagefrom
tionalbehavior.Finally,thepatientscanreadonthedisplaythe baseline. The main secondary endpoint was the presence of
actualbalancebetweenthetotalcalorieintakeandthecalories metabolic syndrome. Further secondary endpoints were abso-
usedupbythebasalmetabolicrateplustheirphysicalactivity. luteweightlossandchangesinbodymassindex(BMI),waist
These data and the daily body weights from the subjects’ circumference,andlaboratoryparameters.
personal scales were transmitted once a week to a server in Thestudywasdesignedtodetectdifferencesinweightloss
Magdeburg University Hospital by means of a USB connec- atthe12-monthvisitbetweenthe3treatmentarmswithapower
tiontoahomecomputerwithautomaticextractionofnewdata. of at least 80% if the difference amounted to 5 kg or more.
JOURNALOFTHEAMERICANCOLLEGEOFNUTRITION 3
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
WeightLossinPatientswithMetabolicSyndrome
As a simplified scenario for the sample size calculation we the weight loss was compared between the 3 visits based on
used Bonferroni-corrected pairwise t tests at the 2-sided level thesamemixedmodel(alsowithBonferroniadjustmentfor3
0.05/3=0.0167andassumedacommonstandarddeviationof pairwisevisitcomparisons).
7kginalltreatments.Thiswouldrequireabout45personsper Because dropout is an essential issue in this study (as in
treatmentarm;withasupposeddropoutrateof25%thismeant nearly all diet studies), several missing value strategies were
that60patientshadtoberecruitedforeachtreatmentarm. consideredsimultaneously.Theprimaryanalysis(“original”es-
Webeginwithadescriptionofdemographicandbaselinepa- timatesintheresultstables)usedallavailablemeasurementsat
rametersstratifiedbytreatmentarm,completedbyacomparison correspondingvisits(notethatthemixedmodelapproachdoes
oftheseparametersbetweenthetreatmentarmsinBonferroni- notrequirecompletedatafromallvisits).Insensitivityanaly-
corrected chi-squared tests for gender and Tukey tests for all ses, we substituted missing values from dropouts by multiple
continuousparameters. imputation and by the last observation carried forward strat-
The main analysis for the primary endpoint, the percent- egy(LOCF)aswellasbybaselineobservationcarriedforward
age weight loss, is the comparison between the 3 treatment (BOCF).Formultipleimputationsweused5replications,where
arms.Patientswereallocatedtothe3groupsaccordingtothe missingvaluesweresubstitutedinaMarkovchainMonteCarlo
intention-to-treatprinciple.Weightlossatthe4-month,8-month, methodbasedontheavailablemeasurementsforthepatientat
and12-monthvisitsweremodeledinamixedlinearmodelwith othervisitsandarandomdisturbance.
a random patient effect (intercept) and fixed effects for treat- Analogous analyses were carried out with the continuous
ment arm, visit, baseline value (covariable), and interactions secondary endpoints but with absolute differences from base-
between treatment arm and visit as well as between visit and line.Forvariableswithskeweddistributions(triglycerides,apo
baseline value. Although values from all visits were included B, ALT, AST, C-reactive protein [CRP], glucose, Hb , in-
A1c
in the analyses, the main focus was on the results at the 12- sulin,andHOMA),thetestresults(pvalues)weretakenfrom
month visit. A Bonferroni correction was used to adjust the 3 analyseswithlog-transformeddata,buttheestimatesandconfi-
pairwisecomparisonsbetweenthetreatmentarmsat12months denceintervalswerederivedfromadditionalanalyseswiththe
andalsoforcorrespondingconfidenceintervalsforthepairwise originaldataformoreconvenientpresentationuniformoverall
differences.Inaddition,estimatesofthegroupwisemeanswith variables.
unadjustedconfidenceintervalsandunadjustedpvaluesforthe Themainsecondaryoutcomevariable,metabolicsyndrome,
testsversus0(i.e.,noweightloss)weretakenfromthemixed was considered in pairwise Bonferroni-corrected chi-squared
modelforallvisits.Inasecondaryconsideration,ineachgroup tests.MissingvaluesweretreatedbytheLOCFprotocol.
Table1.BaselineDemographicsofthePatients
pABC pABC p4S
N ABC60 4S58 Controls60 vs4S vsControls vsControls
Gender:No.(%) F:18(30);M:42(70) F:27(47);M:31(53) F:28(47);M:32(53) NS NS NS
Age(years) 50.3 ± 7.8 50.3 ± 8.0 50.1 ± 8.1 NS NS NS
Weight(kg) 104.8 ± 18.5 97.8 ± 16.3 96.1 ± 19.7 NS 0,025 NS
BMI(m2/kg) 34.0 ± 4.9 33.3 ± 5.8 32.6 ± 4.9 NS NS NS
Waist(cm) 111.8 ± 11.8 109.8 ± 11.8 107.9 ± 13.1 NS NS NS
BPsystolic(mmHg) 142.0 ± 16.8 144.2 ± 21.0 140.9 ± 17.6 NS NS NS
BPdiastolic(mmHg) 88.3 ± 10.2 90.2 ± 11.2 88.1 ± 12.6 NS NS NS
Triglycerides(mmol/L) 2.45 ± 1.41 2.22 ± 0.97 2.12 ± 0.81 NS NS NS
Cholesterol(mmol/L) 5.86 ± 1.08 5.82 ± 1.22 5.77 ± 1.19 NS NS NS
HDLcholesterol(mmol/L) 1.14 ± 0.30 1.21 ± 0.32 1.19 ± 0.25 NS NS NS
LDLcholesterol(mmol/L) 3.72 ± 0.92 3.67 ± 1.02 3.62 ± 1.06 NS NS NS
Uricacid(μmol/L) 354.1 ± 85.2 357.9 ± 87.4 342.9 ± 81.0 NS NS NS
AST(μmol/s∗L) 0.51 ± 0.16 0.56 ± 0.23 0.53 ± 0.20 NS NS NS
ALT(μmol/s∗L) 0.65 ± 0.34 0.72 ± 0.54 0.61 ± 0.39 NS NS NS
ApolipoproteinB(g/L) 1.15 ± 0.23 1.16 ± 0.28 1.12 ± 0.28 NS NS NS
CRPhigh-sensitivity(mg/L) 5.62 ± 8.72 3.93 ± 5.85 3.69 ± 5.03 NS NS NS
Glucose(mmol/L) 4.18 ± 0.53 4.21 ± 0.77 4.22 ± 0.77 NS NS NS
Hba1cIFCC(mmol/mol) 39.6 ± 4.8 38.9 ± 5.8 39.2 ± 6.1 NS NS NS
Insulin(pmol/L) 93.8 ± 54.0 88.5 ± 60.3 82.6 ± 54.4 NS NS NS
HOMA 2.42 ± 1.32 2.37 ± 1.92 2.16 ± 1.55 NS NS NS
ABC=ActiveBodyControlProgramofUniversityofMagdeburg,4S=4sigmatelephonecoaching,BMI=bodymassindex,BP=bloodpressure,HDL=high-
densitylipoprotein,LDL=low-densitylipoprotein,AST=Aspartat-Aminotransferase,ALT=Alanin-Aminotransferase,CRP=C-reactiveprotein,IFCC=International
FederationofClinicalChemistry,HOMA=homeostasismodelofassessment.
4 VOL.0,NO.0
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
WeightLossinPatientswithMetabolicSyndrome
AllanalyseswerecarriedoutusingSASVersion9.2(SAS Table2b.ReasonsforDropout
Institute Inc., Cary, NC; procedures FREQ, GLM, MEAN,
ABC 4S Controls
MIXED, MI, MIANALYZE). The tests were carried out at a
significancelevelof0.05. Contactnotpossibleafter12months 5(8%) 4(7%) 16(28%)
Technicalissues 5(8%) 2(3%) 0
Notsatisfiedwiththeprogram 0 1(2%) 3(4%)
Familial/professional 1(2%) 2(3%) 0
RESULTS Metformintherapy 0 1(2%) 3(4%)
ABC=ActiveBodyControlProgramofUniversityofMagdeburg,4S=4sigma
A flowchart of the study is presented in Fig. 1. Six of the
telephonecoaching.
randomized patients were excluded from the final evaluation.
Documentation of the baseline data was lost in 2 cases (both anddecreasedinthecontrolgroupbetween8and12months,
in the control group). Four more patients were found during whereasinthe2interventiongroupstheyincreasedfurther.
thefirst4monthstosufferfromseverepreexistingconditions Thedatacollectedfromtheaccelerometersweregenerallyin
havinganeffectonbodyweightatthebaselinevisit:2severe linewiththegreaterweightlossintheABCgroup.Thisgroup
depressions,1amyotrophiclateralsclerosis,and1cancerofthe hadlongerwalkingdistances(ABC:6.5km/day,4S:5.9km/day)
colon(all4Sgroup). andalowernutritionalenergyinput(ABC:1487kcal/day,4S:
Table 1 gives the baseline data for the remaining patients 1510kcal/day).Noneofthesedifferencesreachedstatisticalsig-
forthe3groups.Astatisticallysignificantdifferencebetween nificance;however,theminordailydifferenceincalorieintake
the groups was observed for the baseline weight, which was andexercise-inducedcalorieburnaddedupoveroneyeartoap-
higher in the ABC group than in the controls. The difference proximatelyanaverageofadditionalnegativebalanceof24,000
is due to an incidental higher proportion of men in the ABC kcalandis,therefore,inlinewiththeadditionalweightlossin
group: (70%) vs 53% in both the 4S group and the controls. theABCgroup.
To compensate for this imbalance, we analyzed the different Table3showstheproportionofcompletingpatientswhose
primaryandsecondarymetricalendpointsnotonlyasthechange relativeweightlossexceeded5%,10%,or15%.Highestvalues
fromthebaselinebutadditionallyincludedthebaselinevalueas wereagainobservedintheABCgroup,inwhichalmostevery
acovariable.Inaddition,therelativeweightlossandthedecrease otherpatientlostmorethan15%oftheirbaselineweight.
in BMI are reported, both of which are less influenced by the Table4showsthechangesinvariousclinicalandbiochemi-
absolutebaselineweight.Table2agivesthedropoutratesinthe calparametersafter12months.Fourpatientsdevelopeddiabetes
3groups.Theseincreasedinthecourseofthestudyandafter12 mellitus(3controls,14S).Theyremainedintheevaluationwith
monthsbecamealmostequalat18%and17%intheABCand theiroriginaldatauntilthebeginningoftherapywithmetformin,
4Sgroupbutat35%weretwiceashighinthecontrolgroup. whichisknowntoinfluencebodyweightandassociatedparame-
Table2bshowsthereasonsfordropout.Lossofsensorwasthe ters.Thereaftertheyweretreatedasdropouts.Thechangesfrom
prevailingtechnicalreasonwithaconsecutiveunwillingnessto baselineinTable4aregivenasadjustedmeansafterdifferent
payasecondsecuritydepositforareplacementinstrument. approachestoaccountforthedropouts.Theoriginalestimates
Fig.2showstheunadjustedindividualweightlosscurvesin fromthemixedmodelapproachusedallavailablemeasurements
kilogramsinthe2interventiongroupsovertheyear;themean atcorrespondingvisits.MIshowsvaluesaftermultipleimputa-
is shown in red. Weight loss did not differ between men and tion,andLOCFandBOCFgivevaluesafterthelastobservation
womeninanyofthegroups,eitherinabsolute(kg)orinrelative carriedforwardandbaselineobservationcarriedforwardproce-
(%)terms.Theadjustedrelativeweightlossesaccordingtothe dure.Inall3groupsbodyweight,bloodpressure,andmostof
mixedmodelevaluationaregiveninFig.3atmonths0,4,8,and theobesity-relatedbiochemicalparametersimprovedrelativeto
12.ItisapparentthatweightlosswasgreatestintheABCgroup baseline(first3columns).Comparedwiththecontrols(columns
4 and 5), the groups with telemonitoring showed statistically
Table2a.DropoutRates
Table 3. Proportions (%) of Patients Completing the Study
WhoseWeightLossExceeded5%,10%,or15%ofTheirBase-
DropoutRates,n(%)
lineWeightafter12Months
4Months 8Months 12Months
WeightLoss ABC 4S Controls
ABC 2 (3%)∗∗ 7 (12%)∗∗ 11 (18%)∗
4S 4 (6%)∗ 8 (13%)∗ 10 (16%)∗ ≥5% 82 68 32
Controls 11 (18%) 20 (32%) 22 (35%) ≥10% 57 43 8
≥15% 43 19 5
ABC=ActiveBodyControlProgramofUniversityofMagdeburg,4S=4sigma
telephonecoaching. ABC=ActiveBodyControlProgramofUniversityofMagdeburg,4S=4sigma
pvs.controls:∗p<0.05.∗∗p<0.01. telephonecoaching.
JOURNALOFTHEAMERICANCOLLEGEOFNUTRITION 5
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
aslortnoCehtnidnaS4dnaCBAspuorGehtnishtnoM21retfayrtsimehcoiBdna,erusserPdoolB,thgieWnisegnahC.4elbaT
suniMS4
suniMCBA
CBA
shtnoM21puorGlortnoC
shtnoM21puorGS4
shtnoM21puorGCBA
slortnoC
slortnoC
S4suniM
enilesaBsuniM
enilesaBsuniM
enilesaBsuniM
IC
%59
p
(cid:2)
IC
%59
p
(cid:2)
IC
%59
p
(cid:2)
IC
%59
p
(cid:2)
IC
%59
p
(cid:2)
IC
%59
p
(cid:2)
etamitsE
)%(ssolthgieW
7.7
1.2
000.0
9.4
5.01
9.4
000.0
7.7
5.5
1.0
140.0
8.2
4.5
1.2
000.0
7.3
2.01
0.7
000.0
6.8
9.21
8.9
000.0
4.11
lanigirO
0.7
3.1
200.0
1.4
5.9
4.3
000.0
4.6
2.5
6.0−
SN
3.2
3.6
6.2
000.0
4.4
3.01
9.6
000.0
6.8
5.21
2.9
000.0
9.01
IM
7.7
5.2
000.0
1.5
6.01
4.5
000.0
0.8
6.5
3.0
220.0
9.2
5.4
5.1
000.0
0.3
6.9
6.6
000.0
1.8
5.21
5.9
000.0
0.11
FCOL
4.7
1.2
000.0
7.4
5.01
1.5
000.0
8.7
8.5
4.0
810.0
1.3
0.4
9.0
200.0
5.2
7.8
6.5
000.0
2.7
8.11
7.8
000.0
3.01
FCOB
)gk(ssolthgieW
6.1−
5.7−
100.0
5.4−
0.5−
9.01−
000.0
9.7−
6.0−
2.6−
310.0
4.3−
5.2−
0.6−
000.0
2.4−
1.7−
4.01−
000.0
8.8−
5.01−
8.31−
000.0
2.21−
lanigirO
0.1−
0.7−
400.0
0.4−
9.3−
3.01−
000.0
1.7−
1.0−
1.6−
930.0
1.3−
6.2−
6.6−
000.0
6.4−
8.6−
4.01−
000.0
6.8−
0.01−
4.31−
000.0
7.11−
IM
2.2−
8.7−
000.0
0.5−
8.5−
3.11−
000.0
6.8−
8.0−
4.6−
700.0
6.3−
7.1−
9.4−
000.0
3.3−
6.6−
9.9−
000.0
3.8−
2.01−
4.31−
000.0
8.11−
FCOL
7.1−
4.7−
000.0
5.4−
4.5−
1.11−
000.0
3.8−
9.0−
6.6−
500.0
8.3−
1.1−
4.4−
100.0
7.2−
6.5−
9.8−
000.0
3.7−
4.9−
7.21−
000.0
0.11−
FCOB
)gk/2m(IMB
7.0−
6.2−
000.0
7.1−
0.2−
9.3−
000.0
9.2−
3.0−
2.2−
400.0
2.1−
6.0−
8.1−
000.0
2.1−
3.2−
4.3−
000.0
8.2−
6.3−
6.4−
000.0
1.4−
lanigirO
3.0−
5.2−
600.0
4.1−
5.1−
5.3−
000.0
5.2−
1.0−
1.2−
320.0
1.1−
8.0−
0.2−
000.0
4.1−
2.2−
4.3−
000.0
8.2−
3.3−
4.4−
000.0
9.3−
IM
8.0−
6.2−
000.0
7.1−
0.2−
8.3−
000.0
9.2−
3.0−
1.2−
400.0
2.1−
5.0−
5.1−
000.0
0.1−
2.2−
2.3−
000.0
7.2−
4.3−
4.4−
000.0
9.3−
FCOL
6.0−
5.2−
000.0
5.1−
0.2−
8.3−
000.0
9.2−
4.0−
3.2−
200.0
3.1−
3.0−
3.1−
400.0
8.0−
8.1−
9.2−
000.0
3.2−
1.3−
2.4−
000.0
7.3−
FCOB
)mc(tsiaW
6.0−
8.7−
710.0
2.4−
0.4−
2.11−
000.0
6.7−
0.0
8.6−
740.0
4.3−
5.4−
8.8−
000.0
7.6−
9.8−
8.21−
000.0
8.01−
3.21−
2.61−
000.0
3.41−
lanigirO
9.0
1.6−
SN
6.2−
8.1−
3.01−
400.0
0.6−
2.0
1.7−
SN
4.3−
1.5−
2.01−
000.0
7.7−
2.8−
2.21−
000.0
2.01−
5.11−
8.51−
000.0
7.31−
IM
2.1−
6.7−
300.0
4.4−
4.4−
8.01−
000.0
6.7−
1.0−
4.6−
540.0
2.3−
5.3−
3.7−
000.0
4.5−
0.8−
6.11−
000.0
8.9−
2.11−
9.41−
000.0
0.31−
FCOL
9.1−
5.8−
100.0
2.5−
0.4−
5.01−
000.0
2.7−
2.1
3.5−
SN
1.2−
2.2−
0.6−
000.0
1.4−
4.7−
2.11−
000.0
3.9−
4.9−
2.31−
000.0
3.11−
FCOB
)gHmm(PBcilotsyS
5.1
6.41−
SN
6.6−
8.2
1.31−
SN
2.5−
9.8
1.6−
SN
4.1
9.0−
7.01−
020.0
8.5−
0.8−
7.61−
000.0
4.21−
7.6−
2.51−
000.0
0.11−
lanigirO
6.5
5.81−
SN
4.6−
6.3
0.31−
SN
7.4−
8.01
2.7−
SN
8.1
4.1−
7.01−
310.0
1.6−
2.6−
8.81−
100.0
5.21−
0.6−
4.51−
000.0
7.01−
IM
3.0−
0.41−
630.0
2.7−
1.2
4.11−
SN
7.4−
3.9
2.4−
SN
5.2
7.0−
6.8−
220.0
6.4−
9.7−
8.51−
000.0
8.11−
4.5−
2.31−
000.0
3.9−
FCOL
3.0
1.31−
SN
4.6−
3.0
0.31−
SN
4.6−
7.6
6.6−
SN
0.0
4.0
4.7−
SN
5.3−
0.6−
8.31−
000.0
9.9−
1.6−
7.31−
000.0
9.9−
FCOB
)gHmm(PBcilotsaiD
2.2
8.6−
SN
3.2−
4.2
5.6−
SN
0.2−
4.4
0.4−
SN
2.0
2.1−
7.6−
500.0
9.3−
8.3−
7.8−
000.0
2.6−
6.3−
4.8−
000.0
0.6−
lanigirO
8.3
9.8−
SN
5.2−
6.2
3.6−
SN
9.1−
7.5
4.4−
SN
6.0
3.1−
3.6−
300.0
8.3−
9.2−
8.9−
200.0
3.6−
1.3−
3.8−
000.0
7.5−
IM
4.1
2.6−
SN
4.2−
3.2
2.5−
SN
4.1−
7.4
8.2−
SN
0.1
1.1−
5.5−
400.0
3.3−
5.3−
9.7−
000.0
7.5−
5.2−
9.6−
000.0
7.4−
FCOL
30.1
05.6−
SN
37.2−
71.0
82.7−
SN
55.3−
9.2
6.4−
SN
8.0−
1.0−
4.4−
440.0
2.2−
8.2−
1.7−
000.0
0.5−
7.3−
9.7−
000.0
8.5−
FCOB
)L/lomm(sedirecylgirT
77.0
93.0−
SN
91.0
12.0
49.0−
630.0
73.0−
00.0
11.1−
SN
55.0−
61.0
45.0−
430.0
91.0−
23.0
33.0−
700.0
00.0
42.0−
78.0−
000.0
65.0−
lanigirO
36.0
44.0−
SN
90.0
42.0
70.1−
SN
14.0−
32.0
52.1−
SN
15.0−
71.0
44.0−
420.0
31.0−
13.0
93.0−
500.0
40.0−
51.0−
59.0−
000.0
55.0−
IM
65.0
83.0−
SN
90.0
60.0
98.0−
600.0
14.0−
30.0−
89.0−
240.0
05.0−
11.0
34.0−
320.0
61.0−
02.0
53.0−
200.0
70.0−
03.0−
58.0−
000.0
85.0−
FCOL
16.0
03.0−
SN
51.0
61.0
57.0−
420.0
92.0−
10.0
19.0−
SN
54.0−
01.0
24.0−
240.0
61.0−
62.0
72.0−
010.0
00.0
91.0−
17.0−
000.0
54.0−
FCOB
)L/lomm(loretselohC
66.0
70.0−
SN
92.0
34.0
92.0−
SN
70.0
31.0
75.0−
SN
22.0−
51.0−
95.0−
100.0
73.0−
21.0
82.0−
SN
80.0−
01.0−
05.0−
300.0
03.0−
lanigirO
15.0
51.0−
SN
81.0
04.0
24.0−
SN
10.0−
22.0
16.0−
SN
91.0−
80.0−
84.0−
600.0
82.0−
01.0
03.0−
SN
01.0−
60.0−
35.0−
610.0
92.0−
IM
25.0
11.0−
SN
12.0
23.0
13.0−
SN
00.0
11.0
25.0−
SN
02.0−
01.0−
64.0−
200.0
82.0−
11.0
62.0−
SN
70.0−
01.0−
64.0−
300.0
82.0−
FCOL
84.0
11.0−
SN
81.0
62.0
23.0−
SN
30.0−
80.0
15.0−
SN
22.0−
90.0−
34.0−
300.0
62.0−
01.0
52.0−
SN
80.0−
21.0−
64.0−
100.0
92.0−
FCOB
6
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
loretselohcLDH
)L/lomm(
31.0
70.0−
SN
30.0
31.0
70.0−
SN
30.0
01.0
90.0−
SN
10.0
51.0
30.0
300.0
90.0
81.0
60.0
000.0
21.0
81.0
70.0
000.0
31.0
lanigirO
11.0
70.0−
SN
20.0
31.0
90.0−
SN
20.0
11.0
11.0−
SN
00.0
61.0
40.0
100.0
01.0
81.0
60.0
000.0
21.0
81.0
60.0
000.0
21.0
IM
21.0
50.0−
SN
30.0
21.0
50.0−
SN
40.0
90.0
80.0−
SN
10.0
41.0
40.0
100.0
90.0
71.0
70.0
000.0
21.0
81.0
80.0
000.0
31.0
FCOL
31.0
40.0−
SN
40.0
31.0
40.0−
SN
50.0
80.0
80.0−
SN
00.0
01.0
10.0
710.0
60.0
51.0
50.0
000.0
01.0
51.0
60.0
000.0
01.0
FCOB
loretselohcLDL
)L/lomm(
85.0
40.0−
SN
72.0
55.0
60.0−
SN
52.0
82.0
23.0−
SN
20.0−
51.0−
25.0−
000.0
43.0−
01.0
52.0−
SN
70.0−
80.0
62.0−
SN
90.0−
lanigirO
45.0
81.0−
SN
81.0
84.0
41.0−
SN
71.0
92.0
03.0−
SN
10.0−
20.0−
05.0−
830.0
62.0−
80.0
52.0−
SN
80.0−
11.0
92.0−
SN
90.0−
IM
84.0
30.0−
SN
32.0
74.0
50.0−
SN
12.0
52.0
82.0−
SN
20.0−
31.0−
24.0−
000.0
82.0−
01.0
02.0−
SN
50.0−
90.0
22.0−
SN
70.0−
FCOL
93.0
01.0−
SN
51.0
33.0
61.0−
SN
80.0
91.0
13.0−
SN
60.0−
70.0−
53.0−
400.0
12.0−
80.0
12.0−
SN
60.0−
20.0
72.0−
SN
31.0−
FCOB
BnietorpopilopA
)L/g(
21.0
40.0−
SN
40.0
20.0
41.0−
SN
60.0−
20.0−
81.0−
110.0
01.0−
40.0−
41.0−
200.0
90.0−
00.0
90.0−
130.0
50.0−
01.0−
91.0−
000.0
51.0−
lanigirO
11.0
60.0−
SN
30.0
40.0
61.0−
SN
60.0−
00.0
71.0−
230.0
90.0−
10.0−
31.0−
420.0
70.0−
00.0
90.0−
140.0
50.0−
80.0−
81.0−
000.0
31.0−
IM
01.0
50.0−
SN
30.0
10.0
31.0−
SN
60.0−
10.0−
61.0−
310.0
90.0−
30.0−
11.0−
300.0
70.0−
00.0
90.0−
540.0
40.0−
90.0−
71.0−
000.0
31.0−
FCOL
90.0
50.0−
SN
20.0
10.0
31.0−
330.0
60.0−
10.0−
51.0−
220.0
80.0−
20.0−
01.0−
500.0
60.0−
10.0−
90.0−
010.0
50.0−
90.0−
71.0−
000.0
31.0−
FCOB dicacirU
)L/lomm(
8.52
3.62−
SN
3.0−
5.32
7.82−
SN
6.2−
6.22
2.72−
SN
3.2−
1.0
2.13−
SN
6.51−
4.1−
2.03−
130.0
8.51−
7.3−
6.23−
410.0
1.81−
lanigirO
3.42
2.92−
SN
5.2−
7.42
8.23−
SN
0.4−
0.22
1.52−
SN
6.1−
0.1
3.92−
SN
2.41−
8.1−
5.13−
920.0
6.61−
1.3−
3.33−
910.0
2.81−
IM
7.42
8.91−
SN
4.2
7.51
2.82−
SN
3.6−
3.31
7.03−
SN
7.8−
6.1−
2.72−
820.0
4.41−
0.1
8.42−
SN
9.11−
1.8−
2.33−
100.0
7.02−
FCOL
1.41
7.82−
SN
3.7−
8.51
4.62−
SN
3.5−
2.32
1.91−
SN
1.2
3.3
3.12−
SN
0.9−
0.4−
8.82−
010.0
4.61−
2.2−
4.62−
020.0
3.41−
FCOB
)L∗s/lomμ(TLA
30.0
51.0−
700.0
60.0−
60.0
11.0−
SN
30.0−
21.0
50.0−
SN
30.0
90.0−
91.0−
000.0
41.0−
51.0−
52.0−
000.0
02.0−
21.0−
12.0−
000.0
71.0−
lanigirO
50.0
41.0−
SN
40.0−
80.0
11.0−
SN
20.0−
11.0
50.0−
SN
30.0
11.0−
22.0−
000.0
71.0−
61.0−
62.0−
000.0
12.0−
31.0−
32.0−
000.0
81.0−
IM
00.0
02.0−
100.0
01.0−
20.0
81.0−
SN
80.0−
21.0
80.0−
SN
20.0
40.0−
51.0−
100.0
90.0−
41.0−
52.0−
000.0
02.0−
21.0−
32.0−
000.0
81.0−
FCOL
30.0
71.0−
110.0
70.0−
50.0
51.0−
SN
50.0−
21.0
80.0−
SN
20.0
30.0−
41.0−
600.0
80.0−
01.0−
12.0−
000.0
51.0−
80.0−
91.0−
000.0
31.0−
FCOB
)L∗s/lomμ(TSA
10.0
11.0−
SN
50.0−
60.0
60.0−
SN
00.0
11.0
10.0−
640.0
50.0
10.0−
80.0−
500.0
50.0−
60.0−
31.0−
000.0
01.0−
20.0−
80.0−
500.0
50.0−
lanigirO
30.0
01.0−
SN
40.0−
70.0
60.0−
SN
00.0
11.0
20.0−
SN
40.0
20.0−
01.0−
200.0
60.0−
70.0−
31.0−
000.0
01.0−
20.0−
90.0−
100.0
60.0−
IM
10.0−
21.0−
210.0
60.0−
30.0
70.0−
SN
20.0−
01.0
10.0−
SN
40.0
10.0−
70.0−
200.0
40.0−
70.0−
41.0−
000.0
01.0−
30.0−
90.0−
000.0
60.0−
FCOL
00.0
11.0−
440.0
50.0−
40.0
60.0−
SN
10.0−
90.0
10.0−
SN
40.0
10.0
50.0−
050.0
20.0−
50.0−
11.0−
000.0
80.0−
00.0
60.0−
710.0
30.0−
FCOB –hgihPRC
ytivitisnes
)L/gm(
54.1
07.3−
SN
21.1−
25.0
56.4−
040.0
60.2−
65.1
44.3−
SN
49.0−
93.1
86.1−
SN
51.0−
81.0
27.2−
100.0
72.1−
87.0−
36.3−
000.0
12.2−
lanigirO
09.1
09.2−
SN
05.0−
18.0
41.4−
SN
76.1−
13.1
46.3−
SN
61.1−
20.1
27.1−
820.0
53.0−
05.0
02.2−
000.0
58.0−
25.0−
15.3−
000.0
10.2−
IM
15.2
29.1−
SN
92.0
11.1
03.3−
640.0
01.1−
18.0
95.3−
SN
93.1−
64.0
11.2−
820.0
38.0−
57.0
28.1−
100.0
35.0−
76.0−
81.3−
000.0
29.1−
FCOL
50.1
00.3−
SN
79.0−
52.0
77.3−
620.0
67.1−
32.1
97.2−
SN
87.0−
42.1
11.1−
SN
60.0
62.0
80.2−
400.0
19.0−
55.0−
48.2−
000.0
07.1−
FCOB
)egaptxennodeunitnoC(
7
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
)deunitnoC(aslortnoCehtnidnaS4dnaCBAspuorGehtnishtnoM21retfayrtsimehcoiBdna,erusserPdoolB,thgieWnisegnahC.4elbaT
suniMS4
suniMCBA
CBA
shtnoM21puorGlortnoC
shtnoM21puorGS4
shtnoM21puorGCBA
slortnoC
slortnoC
S4suniM
enilesaBsuniM
enilesaBsuniM
enilesaBsuniM
IC
%59
p
(cid:2)
IC
%59
p
(cid:2)
IC
%59
p
(cid:2)
IC
%59
p
(cid:2)
IC
%59
p
(cid:2)
IC
%59
p
(cid:2)
etamitsE
)L/lomm(esoculG
30.0−
06.0−
SN
23.0−
10.0
65.0−
SN
82.0−
13.0
32.0−
SN
40.0
72.0
70.0−
SN
01.0
60.0−
83.0−
310.0
22.0−
20.0−
43.0−
920.0
81.0−
lanigirO
01.0
15.0−
SN
12.0−
91.0
26.0−
SN
12.0−
92.0
03.0−
SN
10.0−
62.0
91.0−
SN
30.0
20.0−
33.0−
830.0
71.0−
10.0−
53.0−
620.0
81.0−
IM
20.0−
05.0−
SN
62.0−
30.0−
05.0−
SN
62.0−
42.0
42.0−
SN
00.0
42.0
30.0−
SN
11.0
20.0−
03.0−
SN
61.0−
20.0−
03.0−
030.0
61.0−
FCOL
30.0−
94.0−
130.0
62.0−
40.0
14.0−
SN
81.0−
13.0
51.0−
SN
80.0
91.0
70.0−
SN
60.0
70.0−
33.0−
100.0
02.0−
10.0
52.0−
SN
21.0−
FCOB
CCFIc1AbH
)lom/lomm(
01.0−
73.3−
SN
37.1−
15.0−
87.3−
800.0
51.2−
61.1
99.1−
SN
14.0−
13.2
43.0
310.0
23.1
05.0
23.1−
SN
14.0−
80.0
37.1−
SN
28.0−
lanigirO
30.0−
50.3−
SN
45.1−
10.0
14.3−
SN
07.1−
35.1
58.1−
SN
61.0−
60.2
92.0
610.0
71.1
35.0
62.1−
SN
73.0−
55.0
16.1−
SN
35.0−
IM
00.0
40.3−
SN
25.1−
32.0−
42.3−
210.0
37.1−
03.1
37.1−
SN
12.0−
59.1
02.0
810.0
80.1
44.0
33.1−
SN
44.0−
12.0
25.1−
SN
66.0−
FCOL
22.0
34.2−
SN
11.1−
61.0−
87.2−
830.0
74.1−
59.0
86.1−
SN
63.0−
15.1
10.0−
SN
57.0
14.0
31.1−
SN
63.0−
30.0
74.1−
SN
27.0−
FCOB
)L/lomp(nilusnI
1.11
9.24−
SN
9.51−
1.4
8.94−
400.0
8.22−
5.81
4.23−
540.0
9.6−
4.6
3.62−
010.0
0.01−
2.11−
6.04−
000.0
9.52−
1.81−
5.74−
000.0
8.23−
lanigirO
8.51
1.14−
SN
6.21−
5.7
6.44−
320.0
5.81−
0.22
9.33−
SN
9.5−
7.3
6.03−
600.0
4.31−
6.9−
5.24−
000.0
1.62−
2.71−
8.64−
000.0
0.23−
IM
8.4
0.04−
SN
6.71−
2.5
2.93−
200.0
0.71−
9.22
6.12−
SN
6.0
5.6
3.91−
920.0
4.6−
0.11−
0.73−
000.0
0.42−
7.01−
0.63−
000.0
4.32−
FCOL
8.4
0.04−
SN
6.71−
2.5
2.93−
200.0
0.71−
9.22
6.12−
SN
6.0
5.6
3.91−
920.0
4.6−
0.11−
0.73−
000.0
0.42−
7.01−
0.63−
000.0
4.32−
FCOB
AMOH
91.0
92.1−
SN
55.0−
70.0
24.1−
400.0
86.0−
85.0
48.0−
SN
31.0−
12.0
76.0−
910.0
32.0−
83.0−
81.1−
000.0
87.0−
05.0−
23.1−
000.0
19.0−
lanigirO
53.0
70.1−
SN
63.0−
42.0
82.1−
050.0
25.0−
84.0
18.0−
SN
61.0−
40.0
77.0−
200.0
63.0−
23.0−
21.1−
000.0
27.0−
74.0−
03.1−
000.0
88.0−
IM
30.0
02.1−
SN
95.0−
11.0
01.1−
500.0
94.0−
07.0
15.0−
SN
90.0
32.0
84.0−
SN
21.0−
53.0−
60.1−
000.0
17.0−
72.0−
69.0−
000.0
26.0−
FCOL
30.0
02.1−
SN
95.0−
11.0
01.1−
500.0
94.0−
07.0
15.0−
SN
90.0
32.0
84.0−
SN
21.0−
53.0−
60.1−
000.0
17.0−
72.0−
69.0−
000.0
26.0−
FCOB
deirracnoitavresboenilesab=FCOB,drawrofdeirracnoitavresbotsal=FCOL,noitatupmielpitlum=IM,lavretniecnedfinoc=IC,gnihcaocenohpeletamgis4=S4,grubedgaMfoytisrevinUfomargorPlortnoCydoBevitcA=CBA =CCFI,nietorpevitcaer-C=PRC,esarefsnartonimA-tatrapsA=TSA,esarefsnartonimA-ninalA=TLA,nietorpopilytisned-wol=LDL,nietorpopilytisned-hgih=LDH,erusserpdoolb=PB,xednissamydob=IMB,drawrof
.tnemssessafoledomsisatsoemoh=AMOH,yrtsimehClacinilCfonoitaredeFlanoitanretnI
oT.stisivllamorfatadelbaliavallasesuhcihw,hcaorppaledomdeximehtmorfnekatstlusererasetamitselanigirO.spuorgehtneewtebsecnereffidenilesabrofetasnepmocotslevelenilesabotdetsujdaerewerehnevigsecnereffidllAa
.spuorgehtneewtebsecnereffidevigthgirehtnosnmuloc3ehT.FCOBdna,FCOL,IM:detneserperasehcaorppa3,stuopordroftcerroc
8
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
WeightLossinPatientswithMetabolicSyndrome
Fig.2.Individualabsoluteweightlossesinkilogramsinthe2interventiongroupsovertheentirestudy.Redlinesrepresentthemeanweightloss
(unadjustedkilograms)ineachgroup.Afrequentweightincreaseby2to3kgafter240daysreflectsthetimearoundChristmasandwascorrectedin
mostcasesthereafter.(Colorfigureavailableonline.)
greatereffectsonrelativeandabsoluteweight,BMI,andwaist DISCUSSION
circumference and, in the ABC group only, on triglycerides,
CRP,Hb ,andtheparametersofinsulinresistance.Themag- The major finding of this study is that telemonitoring of
A1c
nitude oftheeffects was greatestforthehigh-sensitivityCRP both physical activity and food intake considerably improves
(−48%and−28%)andfortheHOMAindex(−38%and−36%) weightreductionandcorrectsmetabolicsyndromeinamajority
in the ABC and 4S groups, respectively. If we compare ABC ofpatients.Withregardtocommunicationwiththepatients,the
with4S,theformerwasmoreeffectivewithrespecttotheabso- weeklylettersoftheABCprogramweremoreeffectivethanthe
luteandtherelativeweight,BMI,aswellasapolipoproteinB. monthlytelephonecallsinthe4Sgroup.
QualityoflifewasassessedbymeansoftheWHO-5ques- The magnitude of the observed weight loss can be re-
tionnaire[16].Thereturnratesafter12monthswere62%,57%, garded as quite satisfactory, in particular in the ABC group,
and 45% in groups ABC, 4S, and controls, respectively, and withareductionofadjustedbodyweightby12.2kg(11.4%).
the well-being indices increased by 44% (p < 0.001), 33% A weight reduction program is regarded as medically rele-
(p<0.001),and20%(nonsignificant). vant when an individual loses more than 5% of the baseline
Fig.4showstheproportionofpatientsforwhomadiagnosis weight [17–21]. This aim was achieved in 82% of the sub-
ofmetabolicsyndromewasnolongerapplicableafter12months jects completing the study in the ABC group and in 68%
because one or more of the International Diabetes Federation in the 4S group. The substantial > 15% weight loss was
criteriahaddisappeared.Thisratewas33%inthecontrolgroup, achieved by a remarkable 43% of the subjects in the ABC
asopposedto41%inthe4Sgroupand58%intheABCgroup. group.
Fig.3.Relativeweightlossesinthe2interventiongroupsandinthecontrolgroupafter4,8,and12months.Thesedataaretakenfromthemixed
modelapproach,whichusedallavailabledataatalltimepoints.Thechangesbetweenmonths8and12arenotstatisticallysignificantbuttheweight
losstrendsshowafurtherincreaseingroupsABCand4Sbutadecreaseinthecontrolgroup.
JOURNALOFTHEAMERICANCOLLEGEOFNUTRITION 9
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
WeightLossinPatientswithMetabolicSyndrome
social support was ensured by the ABC letters showing the
weightlosscurvesoftheotherpatients,thusintroducinggroup
dynamics.Theprogramwasstructuredintermsofgoalsfordiet
andactivity,withregularfeedback.Finally,individualtailoring
wasensuredbyspecificreactionsofthecarerstothenutritional
andphysicaldatatransmittedtothemviatheInternet.
Theweightreductions wereassociatedwithrelevant bene-
fitsinbloodpressureandinbiochemicalparameters.Themost
pronounced effect was the improvement in parameters known
tobeassociatedwithinsulinresistance.Thisfindingstrength-
ensourbeliefthatthe2combinedinterventionmeasuresusedin
Fig.4.Proportionsofpatientsfreefrommetabolicsyndromeafter12 thisstudy,namely,alow-caloriedietreplacinghigh-GIcarbohy-
months(datafromLOCFevaluation). drateswithlow-GIcarbohydratesplusanincreaseinmoderate
physical activity, reinforce each other in reducing insulin re-
Mobiletechnologyhasbeenusedrepeatedlyinweightloss sistance. The number of patients with a baseline pathological
studies,butthetechnicalapproachesdifferedconsiderably.Sev- HOMA index decreased from 18 to 4 after 12 months in the
eralstudiesusedPDAs,mobilephones,andtheInternettoex- ABCgroup(−78%)andfrom13to5inthe4Sgroup(−61%).
change written information concerning meals, activities, and Theoverallimprovementsarealsoreflectedinthesatisfyingpro-
respective recommendations. Intervention studies of this kind portionofpatientsinwhomadiagnosisofmetabolicsyndrome
during 1 year [22–27] report weight losses of between 1.3 kg wasnolongerapplicable(Fig.4).
[25]and7.6kg[24].Studiesusingpedometersoraccelerome- Thefindingthateventhecontrolgrouplost3.7kg(“original”
terstomeasurephysicalactivityarelessfrequent[28–31].All inTable4)warrantsdiscussion,inparticularbecausethiswas
included regular face-to-face counseling and were carried out accompaniedbya33%reductionintheoccurrenceofmetabolic
forperiodsshorterthaninthepresentstudy.Richardsonetal. syndromeinthisgroup(Fig.4).Threepointsmaybeconsidered.
[29]achievedaweightlossof4.1lbsafter3weeksin12partici- The first is that we believe that the instruction given to all 3
pants(BMI37),andPolzienetal.[28]reportedaweightlossof interventiongroups,namely,therecommendationsconcerning
6.2kgin19patients(BMI32.6)after12weeks.Andersenetal. theMagdeburgDualDietandoptimizedphysicalexercise,was
[31]reporteddatathatcanbecomparedwithourresults.They quite effective. Secondly, this instruction was given at a time
advised20women(BMI32.4)toobservea1200kcal/ddietand atwhichtheparticipantsbecameconcernedabouthealthrisks
toincreasetheirmoderatephysicalactivityby30minutesper detected in their initial physical and blood examinations. The
dayover16weeks.Inaddition,thepatientsworeaccelerometers thirdpointconcernsapotentialselectionbias.Thecontrolgroup
whosereadings wereevaluated ateachof16weekly counsel- hadthehighestrateofdropouts(36%)asopposedto16%and
ing meetings. This group lost 8.7% (7.9 kg), which compares 18% in the other 2 groups. It is probable that the lost cases
wellwithour4-monthweightreductionsof9.2%intheABC werethosewiththesmallestweightlosses.Thisassumptionis
groupandof7.5%inthe4Sgroup.Oureffectsare,therefore, supportedbytheintention-to-treatassessmentusingtheLOCF
inlinewithsatisfactoryresultsobtainedbyotherinvestigators. andBOCFprotocols(Table4),whichyieldedweightlossesof
However, our study extends the knowledge taken from earlier 3.0and2.5kginsteadof3.7kgfromthe“original”evaluationfor
studiesin2respects:inthefirstplace,higherweightlossescan thecontrolgroup.Itmaybethereforeconcludedthattheresults
beachievedbylongerinterventions(Figs.2and3).Secondly, forthecontrolsubjectswhocompletedthestudyoverestimate
thisweightlosscanbeachievedbytelemonitoringwithoutface- thetrueeffects.
to-facecounseling,whichistime-consumingforbothpatients Thisstudyalsocompared2methodsofcommunicationbe-
andcarers. tweenthecarersandthepatients.Theresultsshowclearlythat
Whatarethemajorelementscontributingtothesefavorable weekly information letters are better than monthly telephone
results?Inherreviewoftechnology-basedweightlossinterven- calls. This was not expected at the outset, because communi-
tionsAnnaKhaylis[3]concludedthat5keycomponentsarere- cationbymailoccurredentirelywithoutpersonalcontactfora
quiredforeffectiveweightloss:self-monitoring,counselorfeed- wholeyear,whereasthemonthlytelephonecallsallowedabout
backandcommunication,socialsupport,astructuredprogram, 20 minutes of personal attention each time. We believe that 3
andtheuseofanindividuallytailoredprogram.These5compo- aspectscontributetothebettereffectintheABCgroup.First,
nentsareindeedelementsoftheinterventionusedinourstudy,in the feedback was more frequent: weekly instead of monthly.
particularintheABCgroup.Self-monitoringiscarriedoutusing Second,aletterprovideswrittendocumentationofthepatient’s
thescreenoftheAipermotioninstrument.Counselorfeedback data,inparticularofhisorherprogressandofthecarers’mo-
was provided by mail (ABC) or by telephone (4S). A kind of tivatingresponses.Finally,anelementofgroupdynamicswas
10 VOL.0,NO.0
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
WeightLossinPatientswithMetabolicSyndrome
introducedbydisplayingtheweightlosscurvesofotherpatients FUNDING
inthegivengroup.
Oneimportantquestioninallweightreductionprogramsis Thisstudywasembeddedwithinthe“lifescience.biz”project
thedropoutrate.Inthisstudytheratesafter1yearwere18% kindlycofundedbytheGermanFederalMinistryofEducation
intheABCgroupand17%inthe4Sgroup.Arecentstudyof andResearch(BMBF),referencenumber01FC08063.
772participantsusingaconventionalweightreductionprogram
knownworldwide[32]reporteda12-monthdropoutrateof39%,
whichismorethantwiceashigh.Thissatisfactoryadherence
REFERENCES
to the program most probably reflects an important advantage
oftelemonitoring,namely,thatthepatientsdonotlosetimeby
1. GrundySM,BrewerHGJr,CleemanJI,SmithSCJr,LenfantC:
visitingtheircarers.
Definition of metabolic syndrome: report of the National Heart,
Asecond majorquestionrelatingtoweightreduction con-
Lung,andBloodInstitute/AmericanHeartAssociationConference
cernsreboundweightgain.Inmanystudiesweightlossreachesa
onScientificIssuesRelatedtoDefinition.ReviewedbyJohnBeilby.
maximumafterabout6monthsandisthenfollowedbyasteady
Circulation109:433–438,2004.
weight gain [33,34]. Such weight gain was observed in our
2. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT,
studyonlyinthecontrolgroupafter8months(Fig.3).Groups MoodieML,GortmakerSL:Theglobalobesitypandemic:shaped
ABCand4Sshowedadditional—althoughsmall—increasesin by global drivers and local environments. Lancet 378:804–814,
weightloss(Figs.2and3).Onemajorreasonforthefrequent 2011.
failure to maintain an achieved weight loss is that intake and 3. KhaylisA,YiaslasT,BergstromJ,Gore-FeltonC:Areviewofeffi-
storageofnutritionalenergyisoneofthemostimportantself- cacioustechnology-basedweight-lossinterventions:fivekeycom-
preservation instincts. Continuous suppression of this instinct, ponents.Telemede-Health16:931–938,2010.
4. NeveM,MorganPJ,JonesPR,CollinsCE:Effectivenessofweb-
particularlywhenoneisconfrontedwithawealthofcalorie-rich
basedinterventionsinachievingweightlossandweightlossmain-
foodandpowerfuladvertisementsforitsconsumption,requires
tenanceinoverweightandobeseadults:asystematicreviewwith
more willpower than many individuals can exert. In contrast,
meta-analysis.ObesRev11:306–321,2011.
increasingandmaintainingphysicalactivitymayinthelongrun
5. Bacigalupo R, Cudd P, Littlewood C, Bissell P, Hawley MS,
be easier, especially when one is rewarded by daily readings
BuckleyWoodsH:Interventionsemployingmobiletechnologyfor
of personal achievement in combination with regular positive overweightandobesity:anearlysystematicreviewofrandomized
feedbackfromarespectedcarer. controlledtrials.ObesRev14:279–291,2013.
6. Luley C, Blaik A, Aronica S, Dierkes J, Kropf S, Westphal S:
Evaluationofthreenewstrategiestofightobesityinfamilies.JNutr
STRENGTHS,LIMITATIONS, Metab2010:751905,2010.
ANDCONCLUSION 7. LuleyC,BlaikA,ReschkeK,KloseS,WestphalS:Weightloss
in obese patients with type 2 diabetes: effects of telemonitoring
Thestrengthsofthisstudyaresufficientlylargegroupsizes, plusadietcombination—theActiveBodyControl(ABC)Program.
DiabetesResClinPract91:286–292,2011.
durationoftheintervention,andanelaborateintent-to-treateval-
8. AlbertiKG,ZimmetP,ShawJ:Metabolicsyndrome—anewworld-
uationofthedata.Alimitationisthatthedatafordropoutscan
widedefinition.AconsensusstatementfromtheInternationalDia-
onlybeestimated,asinmanyotherweightlossstudies.Over-
betesFederation.DiabetMed23:469–480,2006.
estimation(e.g.,intheLOCFprocedure)isprobable,asisun-
9. LudwigDS:Noveltreatmentsforobesity.AsiaPacJClinNutr.12:
derestimation(e.g.,inBOCF).Inaddition,therewasacertain
(Suppl8),2003.
imbalanceinbaselineweightcausedbyahigherproportionof 10. WormN:“Glu¨cklichundSchlank.MitvielEiweißunddemRichti-
menintheABCgroup.Thismayhaveonlypartlybeenbalanced gen Fett. Die Logi-Methode in Theorie und Ku¨che.” [Happy and
byreportingparametersthatarelessdependentofthebaseline slim:withplentyofproteinandtherightfat.TheLOGI-methodin
weight such as relative weight loss and lowering of BMI. A theoryandkitchen]Lu¨nen,Germany:SystemedVerlag,2003.
further limitation of this study is that it does not allow one to 11. Wood RJ, Fernandez ML: Carbohydrate-restricted versus low-
decidewhichofthetelemonitoringcomponentsismoreeffec- glycemic-index diets for the treatment of insulin resistance and
tive:physicalactivityornutrition.Finally,moreworkisneeded metabolicsyndrome.NutrRev67:179–183,2009.
12. Janiszewski PM, Ross R: The utility of physical activity in the
totestthelong-termeffectsofthisnewtreatmentstrategy.
managementofglobalcardiometabolicrisk.Obesity(SilverSpring)
Takentogether,theresultsshowthattelemonitoringofnu-
17:(Suppl3)S3–S14,2009.
trition and physical activity without intermittent face-to-face
13. CorrellM,HanssenH,GrimmeC,ZelgerO,ErtlmeierM,Schweizer
counselingcanyieldsatisfactoryweightloss,inparticularwhen
T, Ko¨hler F, Halle M, Schmidt-Trucksa¨ss A: Abscha¨tzung des
communicationwiththepatientsisbyweeklylettersasinthe
ko¨rperlichen Aktivita¨tsmaßes mittels Aktivita¨tssensor bei Patien-
ABCgroup.Inassociationwithweightloss,therewererelevant tenmitchronischerHerzinsuffizienz[Abstract].DtschZSportmed
improvementsinsymptomsofmetabolicsyndrome. 58:222,2007.
JOURNALOFTHEAMERICANCOLLEGEOFNUTRITION 11
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
WeightLossinPatientswithMetabolicSyndrome
14. Jehn M, Schmidt-Trucksa¨ess A, Schuster T, Hanssen H, Weis 26. McTigueKM,ConroyMB,HessR,BryceCL,FiorilloAB,Fischer
M, Halle M, Koehler F: Accelerometer-based quantification of GS,MilasNC,Simkin-SilvermanLR:UsingtheInternettotranslate
6-minutewalktestperformanceinpatientswithchronicheartfail- an evidence-based lifestyle intervention into practice. Telemed J
ure:applicabilityintelemedicine.JCardFail15:334–340,2009. e-Health15:851–858,2010.
15. HaffnerSM,MiettinenH,SternMP:Thehomeostasismodelinthe 27. MiccoN,GoldB,BuzzellP,LeonardH,PintauroS,Harvey-Berino
SanAntonioHeartStudy.DiabetesCare20:1087–1092,1997. J:Minimalin-personsupportasanadjuncttoInternetobesitytreat-
16. BechP:Measuringthedimensionsofpsychologicalgeneralwell- ment.AnnBehavMed33:49–56,2007.
beingbytheWHO-5.QoLNewsletter32:15–16,2004. 28. Polzien KM, Jakicic JM, Tate DF, Otto AD: The efficacy of a
17. NeterJE,StamBE,KokFJ,GrobbeeDE,GeleijnseJM:Influenceof technology-based system in a short-term behavioral weight loss
weightreductiononbloodpressure:ameta-analysisofrandomized intervention.Obesity15:825–830,2007.
controlledtrials.Hypertension42:878–884,2003. 29. RichardsonCR,BrownBB,FoleyS,DialKS,LoweryJC:Feasibil-
18. TheLookAHEADResearchGroup:Long-termeffectsofalifestyle ityofaddingenhancedpedometerfeedbacktonutritionalcounseling
interventiononweightandcardiovascularriskfactorsinindividuals forweightloss.JMedInternetRes7:e56,2005.
withtype2diabetesmellitus:four-yearresultsoftheLookAHEAD 30. HurlingR,CattM,DeBoniM,FairleyBW,HurstT,MurrayP,
trial.ArchInternMed170:1566–1575,2010. RichardsonA,SodhiJS:UsingInternetandmobilephonetechnol-
19. WoodPD,StefanickML,DreonDM,Frey-HewittB,GaraySC, ogytodeliveranautomatedphysicalactivityprogram:randomized
WilliamsPT,SuperkoHR,FortmannSP,AlbersJJ,VranizanKM: controlledtrial.JMedInternetRes9:e7,2007.
Changesinplasmalipidsandlipoproteinsinoverweightmenduring 31. AndersenRE,WaddenTA,BartlettSJ,ZemelB,VerdeTJ,Franck-
weightlossthroughdietingascomparedwithexercise.NEnglJMed owiak SC: Effects of life-style activity vs structured aerobic ex-
319:1173–1179,1988. erciseinobesewomen.Arandomizedtrial.JAMA281:335–340,
20. The Trials of Hypertension Prevention Collaborative Research 1999.
Group: Effects ofweight loss and sodium reductionintervention 32. Jebb SA, Ahern AL, Olson AD, Aston LM, Holzapfel C, Stoll
onbloodpressureandhypertensionincidenceinoverweightpeo- J, Amann-Gassner U, Simpson AE, Fuller NR, Pearson S, Lau
ple with high-normal blood pressure: the Trials of Hypertension NS, Mander AP, Hauner H, Caterson ID: Primary care referral
Prevention,phaseII.ArchInternMed157:657–667,1997. to a commercial provider for weight loss treatment versus stan-
21. KnowlerWC,Barrett-ConnorE,FowlerSE,HammanRF,Lachin dard care: a randomised controlled trial. Lancet 378:1485–1492,
JM,WalkerEA,NathanDM,andtheDiabetesPreventionProgram 2011.
ResearchGroup:Reductionintheincidenceoftype2diabeteswith 33. ElmerPJ,ObarzanekE,VollmerWM,Simons-MortonD,Stevens
lifestyle intervention or metformin. N Engl J Med 346:393–403, VJ,YoungDR,LinPH,ChampagneC,HarshaDW,SvetkeyLP,
2002. ArdJ,BrantleyPJ,ProschanMA,ErlingerTP,AppelLJ:PREMIER
22. Tate DF, Jackvony EH, Wing RR: Effects of Internet behavioral CollaborativeResearchGroup:Effectsofcomprehensivelifestyle
counselingonweightlossinadultsatriskfortype2diabetes:a modificationondiet,weight,physicalfitness,andbloodpressure
randomizedtrial.JAMA289:1833–1836,2003. control:18-monthresultsofarandomizedtrial.AnnInternMed
23. CusslerEC,TeixeiraPJ,GoingSB,HoutkooperLB,MetcalfeLL, 144:485–495,2006.
BlewRM,RickettsJR,LohmanJ,StanfordVA,LohmanTG:Main- 34. Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith
tenanceofweightlossinoverweightmiddle-agedwomenthrough West D, Milas NC, Mattfeldt-Beman M, Belden L, Bragg C,
theInternet.Obesity16:1052–1060,2008. Millstone M, Raczynski J, Brewer A, Singh B, Cohen J: Tri-
24. Harvey-BerinoJ,PintauroS,BuzzellP,GoldEC:EffectofInternet als for the Hypertension Prevention Research Group: Long-term
support on the long-term maintenance of weight loss. Obes Res weight loss and changes in blood pressure: results of the Trials
12:320–329,2004. ofHypertensionPrevention,phaseII.AnnInternMed134:1–11,
25. McConnonA,KirkSF,CockroftJE,HarveyEL,GreenwoodDC, 2006.
ThomasJD,RansleyJK,BojkeL:TheInternetforweightcontrol
inanobesesample:resultsofarandomizedcontrolledtrial.BMC Received August 20, 2012; revision accepted November 11,
HealthServRes7:206–215,2007. 2013.
12 VOL.0,NO.0
4102
rebotcO
90
45:22
ta
]ytisrevinU
nosreyR[
yb
dedaolnwoD
